Aug 2026Signal
Finding the drift without gel
Where our dry-electrode onset detection agrees with clinical PSG — and where it still misses.
Coming soon
Eidolon OnePrototype 001 — 2026
Your best thinking happens asleep
A dry-EEG headband that catches the moment you drift off — and plays back something worth waking up to.
Join the waitlistBuilding the first prototype
Status — building the first prototype
We are building the first prototype, and the waitlist is open now.
Early units go to the waitlist first, in the order people joined. The list is small on purpose.
This first prototype is a step toward a longer-term aim: exploring organoid intelligence — biological systems that may one day help us understand and shape human thought in new ways. We are not there yet; we are starting with careful, measurable sleep research.
How it works
Neuroscience meets your nightstand
Dry electrodes read the slide from wake into early sleep — no gel, no clinic. On-device signal processing finds hypnagogia, the drifting state the protocol depends on, and nothing leaves the band unless you ask it to.
The method comes from published work, not a hunch. Setup is a few minutes, the guidance is written in plain language, and a real person answers when you write in. We would rather explain the science than hide it.
You pick a topic before bed and put the band on. As you drift, it plays a short cue built around that topic, then lets you fall the rest of the way. In the morning the session is waiting for you, not lost.
The idea
Your dreams don't have to be random
The mind at sleep onset is loose, associative, and unusually open. Eidolon points it at the one thing you chose to think about — then gets out of the way.
Why Eidolon
Why people choose Eidolon
Grounded in research
Built on MIT Media Lab's published Dormio and Targeted Dream Incubation work.
Dry EEG, no gel
A fabric band you can put on yourself in bed — no clinic, no mess, no wires.
A cue built per session
The audio is generated around the topic you chose that night, not one scripted line.
Your data stays yours
Sessions live on your device by default. Nothing is sold, and nothing leaves without you.
FAQ
Questions. Answered.
We don't know yet, and we won't pretend to. It is a prototype. Nothing is for sale, and joining the waitlist costs nothing and commits you to nothing. When there is a real price, waitlist members hear it first.
It might not. Sleep-onset cueing is an active area of research, effects vary between people, and some nights nothing lands. We would rather tell you that plainly now than oversell a prototype.
Sessions are stored on your device by default. We do not sell data, and nothing is shared or uploaded unless you explicitly choose to. If we ever offer cloud sync, it will be opt-in and clearly labelled.
A tracker measures your night and reports back in the morning. Eidolon acts during the night — it detects the moment you drift off and plays a short cue in that window. It is about the transition into sleep, not a score for it.
The cue is a quiet audio prompt timed to the drift into sleep, not a shock or a bright light. It is designed to work with the transition rather than interrupt it. There are no implants and nothing invasive — it is a fabric band.
No. The session is captured for you and waiting in the morning, so nothing depends on you waking up and scrambling to write it down before it fades.
We are building the first prototype now, so there is no ship date to promise. The honest answer is: join the waitlist and we will write to you the moment there is something real to try.
Notebook
Latest from the lab
Jul 2026Protocol
Reading Dormio closely
What the original Targeted Dream Incubation study actually claims, and what it carefully does not.
Coming soonJun 2026Method
One scripted line vs. a generated cue
Why we moved from a fixed prompt to a cue built per session, and how we plan to test the difference.
Coming soonOn the horizonLong-term aim
Toward organoid intelligence
We are exploring what biological computation could teach us about cognition. For now, that means responsible research, clear boundaries, and no claims beyond the evidence.
Coming soon